Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NECTAR1: Pyronaridine-artesunate and Primaquine for Malaria Transmission
NCT04049916Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of artesunate + pyronaridine, primaquine in Malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Sep 2019; status: completed.
02
Drugs
artesunate + pyronaridineprimaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT04049916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049916.